Experimental Cell Models for Investigating Neurodegenerative Diseases

被引:1
|
作者
Evangelisti, Cecilia [1 ]
Ramadan, Sherin [2 ]
Orlacchio, Antonio [3 ,4 ]
Panza, Emanuele [1 ,2 ]
机构
[1] Univ Bologna, IRCCS Azienda Osped, Med Genet Unit, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy
[3] Univ Perugia, Dept Med & Surg, I-06123 Perugia, Italy
[4] IRCCS Santa Lucia Fdn, European Ctr Brain Res CERC, Lab Neurogenet, I-00143 Rome, Italy
关键词
primary cells; iPSCs; model organisms; organoid; gene editing; STEM-CELLS; NEURONS; FIBROBLASTS; PATHOLOGY; GENE;
D O I
10.3390/ijms25179747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Experimental models play a pivotal role in biomedical research, facilitating the understanding of disease mechanisms and the development of novel therapeutics. This is particularly true for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and motor neuron disease, which present complex challenges for research and therapy development. In this work, we review the recent literature about experimental models and motor neuron disease. We identified three main categories of models that are highly studied by scientists. In fact, experimental models for investigating these diseases encompass a variety of approaches, including modeling the patient's cell culture, patient-derived induced pluripotent stem cells, and organoids. Each model offers unique advantages and limitations, providing researchers with a range of tools to address complex biological questions. Here, we discuss the characteristics, applications, and recent advancements in terms of each model system, highlighting their contributions to advancing biomedical knowledge and translational research.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] The value of transgenic models for the study of neurodegenerative diseases
    Price, DL
    Wong, PC
    Markowska, AL
    Thinakaran, G
    Lee, MK
    Martin, LJ
    Rothstein, J
    Sisodia, SS
    Borchelt, DR
    NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION, 2001, : 67 - 86
  • [42] Genetically engineered mouse models of neurodegenerative diseases
    Wong, PC
    Cai, HB
    Borchelt, DR
    Price, DL
    NATURE NEUROSCIENCE, 2002, 5 (07) : 633 - 639
  • [43] The establishment and application of animal models for neurodegenerative diseases
    Pan, Jirong
    Zhang, Ling
    Wang, Qian
    Zhao, Dalu
    Huang, Zhibin
    Wei, Chengzhi
    Ma, Xu
    Qin, Chuan
    CHINESE SCIENCE BULLETIN-CHINESE, 2023, 68 (35): : 4754 - 4763
  • [44] Canine models for human genetic neurodegenerative diseases
    Barsoum, SC
    Callahan, HM
    Robinson, K
    Chang, PL
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (05): : 811 - 823
  • [45] Transgenic animals as models of neurodegenerative diseases in humans
    Theuring, F
    Thunecke, M
    Kosciessa, U
    Turner, JD
    TRENDS IN BIOTECHNOLOGY, 1997, 15 (08) : 320 - 325
  • [46] Functional bioengineered tissue models of neurodegenerative diseases
    Mullis, Adam S.
    Kaplan, David L.
    BIOMATERIALS, 2023, 298
  • [47] Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases
    Kaminska, Joanna
    Zoladek, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [48] Mouse models for neurodegenerative diseases and a theory of proteomics
    Klose, J
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 8 - 8
  • [49] Guide to understanding Drosophila models of neurodegenerative diseases
    Jackson, George R.
    PLOS BIOLOGY, 2008, 6 (02) : 236 - 239
  • [50] Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases
    Story, Brett D.
    Miller, Matthew E.
    Bradbury, Allison M.
    Million, Emily D.
    Duan, Dongsheng
    Taghian, Toloo
    Faissler, Dominik
    Fernau, Deborah
    Beecy, Sidney J.
    Gray-Edwards, Heather L.
    FRONTIERS IN VETERINARY SCIENCE, 2020, 7